SCHISTOACT: a protocol for an open-label, five-arm, non-inferiority, individually randomized controlled trial of the efficacy and safety of praziquantel plus artemisinin-based combinations in the treatment of Schistosoma mansoni infection

Peer Review reports

Original Submission
17 Jul 2023	Submitted	Original manuscript
1 Sep 2023	Reviewed	Reviewer Report - Stephen Allen
9 Sep 2023	Reviewed	Reviewer Report - Amgad Rabie
12 Sep 2023	Reviewed	Reviewer Report - Shriya Das
20 Sep 2023	Reviewed	Reviewer Report - Xiangji Ying
31 Oct 2023	Author responded	Author comments - Charles Owuora Obonyo
Resubmission - Version 2
31 Oct 2023	Submitted	Manuscript version 2
3 Nov 2023	Reviewed	Reviewer Report - Amgad Rabie
3 Nov 2023	Reviewed	Reviewer Report - Shriya Das
6 Nov 2023	Reviewed	Reviewer Report - Xiangji Ying
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
7 Nov 2023	Editorially accepted
27 Nov 2023	Article published	10.1186/s13063-023-07790-3

Back to article page